3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
4
Gastrointestinal
2
Thoracic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
3092
Triple Negative Breast Neoplasms
504
Ovarian Neoplasms
224
Colorectal Neoplasms
189
Carcinoma, Non-Small-Cell Lung
187
Prostatic Neoplasms
180
Neoplasms
171
Lung Neoplasms
164
Neoplasm Metastasis
159
Melanoma
116
Stomach Neoplasms
113
Pancreatic Neoplasms
111
Endometrial Neoplasms
105
Uterine Cervical Neoplasms
93
Squamous Cell Carcinoma of Head and Neck
87
Head and Neck Neoplasms
81
Colonic Neoplasms
81
Carcinoma, Intraductal, Noninfiltrating
80
Sarcoma
63
Breast Carcinoma In Situ
61
Carcinoma, Renal Cell
60
Urinary Bladder Neoplasms
59
Esophageal Neoplasms
58
Motor Activity
57
Brain Neoplasms
50
Lymphedema
42
Breast Cancer Female
40
Advanced Breast Cancer
40
Liver Neoplasms
39
Gastrointestinal Neoplasms
38
Interventions
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tertiary Lymphoid Structures
×
Breast
×
1 year
×
Clear all
NCT06084689
2025-09-02
EMPIRE
Institut Bergonié
Phase 2
Withdrawn